Adenosine-associated delivery systems

Mehdi Kazemzadeh-Narbat, Nasim Annabi, Ali Tamayol, Rahmi Oklu, Amyl Ghanem, Ali Khademhosseini

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Adenosine is a naturally occurring purine nucleoside in every cell. Many critical treatments such as modulating irregular heartbeat (arrhythmias), regulation of central nervous system (CNS) activity and inhibiting seizural episodes can be carried out using adenosine. Despite the significant potential therapeutic impact of adenosine and its derivatives, the severe side effects caused by their systemic administration have significantly limited their clinical use. In addition, due to adenosines extremely short half-life in human blood (<10 s), there is an unmet need for sustained delivery systems to enhance efficacy and reduce side effects. In this article, various adenosine delivery techniques, including encapsulation into biodegradable polymers, cell-based delivery, implantable biomaterials and mechanical-based delivery systems, are critically reviewed and the existing challenges are highlighted.

Original languageEnglish (US)
Pages (from-to)580-596
Number of pages17
JournalJournal of Drug Targeting
Volume23
Issue number7-8
DOIs
StatePublished - Sep 14 2015

Fingerprint

Adenosine
Purine Nucleosides
Biocompatible Materials
Half-Life
Cardiac Arrhythmias
Polymers
Central Nervous System
Therapeutics

Keywords

  • Adenosine
  • controlled drug delivery
  • controlled release
  • drug delivery
  • drug targeting
  • nanoparticles
  • targeted drug delivery

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Kazemzadeh-Narbat, M., Annabi, N., Tamayol, A., Oklu, R., Ghanem, A., & Khademhosseini, A. (2015). Adenosine-associated delivery systems. Journal of Drug Targeting, 23(7-8), 580-596. https://doi.org/10.3109/1061186X.2015.1058803

Adenosine-associated delivery systems. / Kazemzadeh-Narbat, Mehdi; Annabi, Nasim; Tamayol, Ali; Oklu, Rahmi; Ghanem, Amyl; Khademhosseini, Ali.

In: Journal of Drug Targeting, Vol. 23, No. 7-8, 14.09.2015, p. 580-596.

Research output: Contribution to journalReview article

Kazemzadeh-Narbat, M, Annabi, N, Tamayol, A, Oklu, R, Ghanem, A & Khademhosseini, A 2015, 'Adenosine-associated delivery systems', Journal of Drug Targeting, vol. 23, no. 7-8, pp. 580-596. https://doi.org/10.3109/1061186X.2015.1058803
Kazemzadeh-Narbat M, Annabi N, Tamayol A, Oklu R, Ghanem A, Khademhosseini A. Adenosine-associated delivery systems. Journal of Drug Targeting. 2015 Sep 14;23(7-8):580-596. https://doi.org/10.3109/1061186X.2015.1058803
Kazemzadeh-Narbat, Mehdi ; Annabi, Nasim ; Tamayol, Ali ; Oklu, Rahmi ; Ghanem, Amyl ; Khademhosseini, Ali. / Adenosine-associated delivery systems. In: Journal of Drug Targeting. 2015 ; Vol. 23, No. 7-8. pp. 580-596.
@article{9fe22e12b8cc4e9b99d57372dc4bc5e0,
title = "Adenosine-associated delivery systems",
abstract = "Adenosine is a naturally occurring purine nucleoside in every cell. Many critical treatments such as modulating irregular heartbeat (arrhythmias), regulation of central nervous system (CNS) activity and inhibiting seizural episodes can be carried out using adenosine. Despite the significant potential therapeutic impact of adenosine and its derivatives, the severe side effects caused by their systemic administration have significantly limited their clinical use. In addition, due to adenosines extremely short half-life in human blood (<10 s), there is an unmet need for sustained delivery systems to enhance efficacy and reduce side effects. In this article, various adenosine delivery techniques, including encapsulation into biodegradable polymers, cell-based delivery, implantable biomaterials and mechanical-based delivery systems, are critically reviewed and the existing challenges are highlighted.",
keywords = "Adenosine, controlled drug delivery, controlled release, drug delivery, drug targeting, nanoparticles, targeted drug delivery",
author = "Mehdi Kazemzadeh-Narbat and Nasim Annabi and Ali Tamayol and Rahmi Oklu and Amyl Ghanem and Ali Khademhosseini",
year = "2015",
month = "9",
day = "14",
doi = "10.3109/1061186X.2015.1058803",
language = "English (US)",
volume = "23",
pages = "580--596",
journal = "Journal of Drug Targeting",
issn = "1061-186X",
publisher = "Informa Healthcare",
number = "7-8",

}

TY - JOUR

T1 - Adenosine-associated delivery systems

AU - Kazemzadeh-Narbat, Mehdi

AU - Annabi, Nasim

AU - Tamayol, Ali

AU - Oklu, Rahmi

AU - Ghanem, Amyl

AU - Khademhosseini, Ali

PY - 2015/9/14

Y1 - 2015/9/14

N2 - Adenosine is a naturally occurring purine nucleoside in every cell. Many critical treatments such as modulating irregular heartbeat (arrhythmias), regulation of central nervous system (CNS) activity and inhibiting seizural episodes can be carried out using adenosine. Despite the significant potential therapeutic impact of adenosine and its derivatives, the severe side effects caused by their systemic administration have significantly limited their clinical use. In addition, due to adenosines extremely short half-life in human blood (<10 s), there is an unmet need for sustained delivery systems to enhance efficacy and reduce side effects. In this article, various adenosine delivery techniques, including encapsulation into biodegradable polymers, cell-based delivery, implantable biomaterials and mechanical-based delivery systems, are critically reviewed and the existing challenges are highlighted.

AB - Adenosine is a naturally occurring purine nucleoside in every cell. Many critical treatments such as modulating irregular heartbeat (arrhythmias), regulation of central nervous system (CNS) activity and inhibiting seizural episodes can be carried out using adenosine. Despite the significant potential therapeutic impact of adenosine and its derivatives, the severe side effects caused by their systemic administration have significantly limited their clinical use. In addition, due to adenosines extremely short half-life in human blood (<10 s), there is an unmet need for sustained delivery systems to enhance efficacy and reduce side effects. In this article, various adenosine delivery techniques, including encapsulation into biodegradable polymers, cell-based delivery, implantable biomaterials and mechanical-based delivery systems, are critically reviewed and the existing challenges are highlighted.

KW - Adenosine

KW - controlled drug delivery

KW - controlled release

KW - drug delivery

KW - drug targeting

KW - nanoparticles

KW - targeted drug delivery

UR - http://www.scopus.com/inward/record.url?scp=84944200961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944200961&partnerID=8YFLogxK

U2 - 10.3109/1061186X.2015.1058803

DO - 10.3109/1061186X.2015.1058803

M3 - Review article

C2 - 26453156

AN - SCOPUS:84944200961

VL - 23

SP - 580

EP - 596

JO - Journal of Drug Targeting

JF - Journal of Drug Targeting

SN - 1061-186X

IS - 7-8

ER -